ArticlePloS one2020

Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells.

Lilla Nagy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.